| <P style="VERTICAL-ALIGN: top; TEXT-INDENT: 21pt"><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">（路透综合讯）</SPAN><SPAN style="FONT-SIZE: 11pt"> - Amarin</SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">公司周四表示，美国食品和药物管理局已经批准</SPAN><SPAN style="FONT-SIZE: 11pt">Vascepa</SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">用于成年严重高甘油三酯血症患者降低甘油三酯水平。</SPAN><SPAN style="FONT-SIZE: 11pt">Vascepa</SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">是作为饮食调整辅助减少高甘油三酯水平的药物。</SPAN><SPAN style="FONT-SIZE: 11pt"> <SPAN></SPAN></SPAN></P>
<P style="VERTICAL-ALIGN: top; TEXT-INDENT: 21pt"><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">它是</SPAN><SPAN style="FONT-SIZE: 11pt">Amarin</SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">公司通过</SPAN><SPAN style="FONT-SIZE: 11pt">FDA</SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">审查的第一个药物。</SPAN><SPAN style="FONT-SIZE: 11pt"> <SPAN></SPAN></SPAN></P>
<P style="VERTICAL-ALIGN: top; TEXT-INDENT: 21pt" sizset="50" sizcache="7"><A name=OLE_LINK5></A><A name=OLE_LINK16></A><A name=OLE_LINK15><SPAN><SPAN><SPAN style="FONT-SIZE: 11pt">Vascep</SPAN></SPAN></SPAN></A><SPAN><SPAN style="FONT-SIZE: 11pt">a</SPAN></SPAN><SPAN></SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">将与葛兰素史克的</SPAN><SPAN style="FONT-SIZE: 11pt">Lovaza</SPAN><SPAN class=st4><SPAN style="FONT-SIZE: 11pt; COLOR: #222222; FONT-FAMILY: 宋体">（欧米加</SPAN></SPAN><SPAN class=st4><SPAN style="FONT-SIZE: 11pt; COLOR: #222222">-3-</SPAN></SPAN><SPAN class=st4><SPAN style="FONT-SIZE: 11pt; COLOR: #222222; FONT-FAMILY: 宋体">酸乙酯）</SPAN></SPAN><SPAN class=st4><SPAN style="FONT-SIZE: 11pt; COLOR: #222222; FONT-FAMILY: 宋体">展开</SPAN></SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">竞争。</SPAN><SPAN style="FONT-SIZE: 11pt"> <SPAN></SPAN></SPAN></P>
<P style="VERTICAL-ALIGN: top; TEXT-INDENT: 21pt"><SPAN style="FONT-SIZE: 11pt">Vascep</SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">预计将于</SPAN><SPAN style="FONT-SIZE: 11pt">2013</SPAN><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">年第一季度上市。</SPAN><SPAN style="FONT-SIZE: 11pt"></SPAN></P>
<P style="TEXT-INDENT: 21pt"><SPAN style="FONT-SIZE: 11pt; FONT-FAMILY: 宋体">阅读全文：</SPAN><SPAN style="FONT-SIZE: 11pt"></SPAN></P>
<P sizset="53" sizcache="7"><SPAN style="FONT-SIZE: 11pt" sizset="53" sizcache="7"><SPAN><FONT size=3> </FONT></SPAN><A href="http://www.rttnews.com/1932604/fda-okays-amarin-s-vascepa-to-reduce-triglyceride-levels-quick-facts.aspx"><FONT color=#800080 size=3>http://www.rttnews.com/1932604/fda-okays-amarin-s-vascepa-to-reduce-triglyceride-levels-quick-facts.aspx</FONT></A></SPAN></P> |
